Aphidicolin induces myogenic differentiation in the human rhabdomyosarcoma cell line KFR. 1994

J Cinatl, and J Cinatl, and P H Driever, and H Rabenau, and M Novak, and M Stefanik, and B Kornhuber, and H W Doerr
Centre of Hygiene, J. W. Goethe-University, Frankfurt a. M., Fed. Rep. of Germany.

The effects of aphidicolin, a specific inhibitor of DNA polymerase alpha, on cell growth, DNA synthesis and myogenic differentiation in the human alveolar rhabdomyosarcoma cell line KFR were studied. The treatment with aphidicolin at 5 x 10(-6) M concentration, which completely inhibited DNA synthesis and cell growth, induced morphological differentiation of small mononuclear cells to elongated, multinucleated (myotube-like) structures. The morphological differentiation was accompanied by the expression of skeletal muscle myosin; about 30% myosin-positive cells were observed after 14 days of treatment, compared to 2.3% in untreated cultures. The results showed that aphidicolin induces differentiation of human rhabdomyosarcoma cells and that multinucleated myotube-like elements may develop simply by cell fusion without cell division and DNA synthesis.

UI MeSH Term Description Entries
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009218 Myosins A diverse superfamily of proteins that function as translocating proteins. They share the common characteristics of being able to bind ACTINS and hydrolyze MgATP. Myosins generally consist of heavy chains which are involved in locomotion, and light chains which are involved in regulation. Within the structure of myosin heavy chain are three domains: the head, the neck and the tail. The head region of the heavy chain contains the actin binding domain and MgATPase domain which provides energy for locomotion. The neck region is involved in binding the light-chains. The tail region provides the anchoring point that maintains the position of the heavy chain. The superfamily of myosins is organized into structural classes based upon the type and arrangement of the subunits they contain. Myosin ATPase,ATPase, Actin-Activated,ATPase, Actomyosin,ATPase, Myosin,Actin-Activated ATPase,Actomyosin ATPase,Actomyosin Adenosinetriphosphatase,Adenosine Triphosphatase, Myosin,Adenosinetriphosphatase, Actomyosin,Adenosinetriphosphatase, Myosin,Myosin,Myosin Adenosinetriphosphatase,ATPase, Actin Activated,Actin Activated ATPase,Myosin Adenosine Triphosphatase
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D016590 Aphidicolin An antiviral antibiotic produced by Cephalosporium aphidicola and other fungi. It inhibits the growth of eukaryotic cells and certain animal viruses by selectively inhibiting the cellular replication of DNA polymerase II or the viral-induced DNA polymerases. The drug may be useful for controlling excessive cell proliferation in patients with cancer, psoriasis or other dermatitis with little or no adverse effect upon non-multiplying cells. Aphidicolin, (3-S-(3alpha,4beta,4abeta,6aalpha,8alpha,9alpha,11aalpha,11balpha))-Isomer,ICI-69653,NSC-234714,NSC-351140,ICI 69653,ICI69653,NSC 234714,NSC 351140,NSC234714,NSC351140
D018232 Rhabdomyosarcoma, Alveolar A form of RHABDOMYOSARCOMA occurring mainly in adolescents and young adults, affecting muscles of the extremities, trunk, orbital region, etc. It is extremely malignant, metastasizing widely at an early stage. Few cures have been achieved and the prognosis is poor. "Alveolar" refers to its microscopic appearance simulating the cells of the respiratory alveolus. (Holland et al., Cancer Medicine, 3d ed, p2188) Rhabdomyosarcoma 2,Alveolar Rhabdomyosarcoma,Alveolar Rhabdomyosarcomas,Rhabdomyosarcomas, Alveolar

Related Publications

J Cinatl, and J Cinatl, and P H Driever, and H Rabenau, and M Novak, and M Stefanik, and B Kornhuber, and H W Doerr
August 1992, The Journal of cell biology,
J Cinatl, and J Cinatl, and P H Driever, and H Rabenau, and M Novak, and M Stefanik, and B Kornhuber, and H W Doerr
September 1990, Cancer research,
J Cinatl, and J Cinatl, and P H Driever, and H Rabenau, and M Novak, and M Stefanik, and B Kornhuber, and H W Doerr
May 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research,
J Cinatl, and J Cinatl, and P H Driever, and H Rabenau, and M Novak, and M Stefanik, and B Kornhuber, and H W Doerr
November 1990, Experimental cell research,
J Cinatl, and J Cinatl, and P H Driever, and H Rabenau, and M Novak, and M Stefanik, and B Kornhuber, and H W Doerr
March 1999, British journal of cancer,
J Cinatl, and J Cinatl, and P H Driever, and H Rabenau, and M Novak, and M Stefanik, and B Kornhuber, and H W Doerr
September 2000, Japanese journal of cancer research : Gann,
J Cinatl, and J Cinatl, and P H Driever, and H Rabenau, and M Novak, and M Stefanik, and B Kornhuber, and H W Doerr
June 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
J Cinatl, and J Cinatl, and P H Driever, and H Rabenau, and M Novak, and M Stefanik, and B Kornhuber, and H W Doerr
May 1995, European journal of cell biology,
J Cinatl, and J Cinatl, and P H Driever, and H Rabenau, and M Novak, and M Stefanik, and B Kornhuber, and H W Doerr
October 1986, The American journal of pathology,
J Cinatl, and J Cinatl, and P H Driever, and H Rabenau, and M Novak, and M Stefanik, and B Kornhuber, and H W Doerr
January 1995, The Journal of pathology,
Copied contents to your clipboard!